Madrigal Pharmaceuticals Inc (MDGL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2010 | 12-2009 | 12-2008 | 12-2007 | 12-2006 | |
| Sales | 14,803 | 144,245 | 2,615 | 743 | 0 |
| Gross Profit | 14,803 | 144,245 | 2,615 | 743 | N/A |
| Operating Expenses | 51,701 | 64,941 | 96,323 | 66,959 | 59,151 |
| Operating Income | -36,898 | 79,304 | -93,708 | -66,216 | -59,151 |
| Interest Expense | 569 | 216 | 0 | 536 | 574 |
| Other Income | 0 | 0 | 1,090 | 3,257 | 2,455 |
| Pre-tax Income | -37,467 | 79,088 | -92,618 | -63,495 | -57,270 |
| Net Income Continuous | -37,467 | 79,088 | -92,618 | -63,495 | -57,270 |
| Net Income | $-37,467 | $79,088 | $-92,618 | $-63,495 | $-57,270 |
| EPS Basic Total Ops | -32.52 | 81.47 | -96.15 | -131.47 | -93.01 |
| EPS Basic Continuous Ops | -32.45 | 81.60 | -95.99 | -68.38 | -89.94 |
| EPS Diluted Total Ops | -32.52 | 81.12 | -96.15 | -131.47 | -93.01 |
| EPS Diluted Continuous Ops | -32.45 | 81.05 | -95.99 | -68.38 | -89.94 |
| EBITDA(a) | $-34,965 | $81,767 | $-90,991 | $-62,865 | $-55,496 |